drugset / Trial / NCT06264141

Evaluation of Nitric Oxide Nasal Spray (NONS) for Treatment of Recurrent Acute Rhinosinusitis

NCT06264141 ↗

Phase 2 Completed 162 enrolled Sanotize Research and Development corp.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A two-week therapy of nitric oxide nasal spray (NONS) vs Placebo (saline nasal spray) initiated immediately after the onset of a new Recurrent Acute Rhinosinusitis (RARS) episode to assess the acceleration to clinical success (cured/much improved symptoms), lack of use of intranasal corticosteroids (INCS) (Day 5, or thereafter) and rescue oral antibiotics (ATBs) (Day 8, or thereafter) after initiation of nitric oxide releasing solution (NORS) platform therapy.

Timeline

Start
2024-01-16
Primary completion
2025-02-22
Completion
2025-11-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitric Oxide Nasal Spray Unknown 0.56 ml Intranasal

Indications